Modifica di Metformina
Attenzione: non hai effettuato l'accesso. Se effettuerai delle modifiche il tuo indirizzo IP sarà visibile pubblicamente. Se accedi o crei un'utenza, le tue modifiche saranno attribuite al tuo nome utente, insieme ad altri benefici.
Questa modifica può essere annullata.
Controlla le differenze mostrate sotto fra le due versioni per essere certo che il contenuto corrisponda a quanto desiderato, e quindi salvare le modifiche per completare la procedura di annullamento.
Versione attuale | Il tuo testo | ||
Riga 1: | Riga 1: | ||
− | {{Avvertenze}}{{#seo: | + | {{Avvertenze}} |
− | |title= | + | {{#seo: |
− | |titlemode=append | + | |title= |
− | |keywords= | + | |titlemode= append |
− | |description= | + | |keywords= |
+ | |description= | ||
}} | }} | ||
− | {{categorytreeall|Ipoglicemizzanti|mode=all|onlyroot= |depth=}} | + | {{categorytreeall|Ipoglicemizzanti|mode=all|onlyroot=|depth=}} |
== SPECIALITÀ == | == SPECIALITÀ == | ||
− | |||
'''METFORMINA:''' | '''METFORMINA:''' | ||
− | + | *'''[[Glucophage]]''' [http://www.dottnet.it/TFI/Allegati.aspx?file=2011-08-002151-Glucophage+500mg.pdf ''500 mg compresse''], [http://www.dottnet.it/TFI/Allegati.aspx?file=2011-05-009276-Glucophage+500mg+polv.pdf ''500 mg bustine''], [http://www.dottnet.it/TFI/Allegati.aspx?file=2011-08-002152-Glucophage+850mg.pdf ''850 mg compresse''], [http://www.dottnet.it/TFI/Allegati.aspx?file=2011-05-009277-Glucophage+850mg+polv.pdf ''850 mg bustine''], [http://www.dottnet.it/TFI/Allegati.aspx?file=2011-08-002153-Glucophage+1000mg+cpr.pdf''1000 mg compresse''] | |
− | *'''[[Glucophage]]''' 500 mg compresse, 500 mg bustine, 850 mg compresse, 850 mg bustine, 1000 mg compresse | + | *'''[[Metbay]]''' 500 mg compresse [http://www.dottnet.it/TFI/Allegati.aspx?file=2010-05-003389-Metbay.pdf''monografia''] |
− | *'''[[Metbay]]''' 500 mg compresse | + | *'''[[Metfonorm]]''' 500 mg compresse, 850 mg compresse, 1000 mg compresse [http://www.dottnet.it/TFI/Allegati.aspx?file=2013-02-002348-Metfonorm.pdf''monografia''] |
− | *'''[[Metfonorm]]''' 500 mg compresse, 850 mg compresse, 1000 mg compresse | + | *'''[[Metforal]]''' 500 mg compresse, 850 mg compresse [http://www.dottnet.it/TFI/Allegati.aspx?file=2004-05-004015-Metforal.pdf''monografia''], 1000 mg compresse [http://www.dottnet.it/TFI/Allegati.aspx?file=2013-04-002408-Metforalmille.pdf''monografia''] |
− | *'''[[Metforal]]''' 500 mg compresse, 850 mg compresse | + | *'''Metformina generico''' 500 mg compresse, 850 mg compresse, 1000 mg compresse [http://www.dottnet.it/TFI/Allegati.aspx?file=2011-08-008794-Metformina+MG.pdf monografia MYLAN GENERICS] |
− | + | *'''[[Zuglimet]]''' [http://www.dottnet.it/TFI/Allegati.aspx?file=2013-03-007496-Zuglimet+500mg.pdf''500 mg compresse''], [http://www.dottnet.it/TFI/Allegati.aspx?file=2013-03-007497-Zuglimet+850mg.pdf''850 mg compresse''], [http://www.dottnet.it/TFI/Allegati.aspx?file=2012-09-007498-Zuglimet+1000mg.pdf''1000 mg compresse''] | |
− | *''' | ||
− | *'''Zuglimet''' [ | ||
'''[[Glibenclamide|GLIBENCLAMIDE]]/METFORMINA:''' | '''[[Glibenclamide|GLIBENCLAMIDE]]/METFORMINA:''' | ||
+ | *'''[[Bieuglicon M]]''' 40CPR RIV 2,5+400MG [http://www.dottnet.it/TFI/Allegati.aspx?file=2007-09-000595-Bi-Euglucon%20M.pdf''monografia''] | ||
+ | *'''[[Diaglimet]]''' 36CPR RIV 5MG+500MG [http://www.dottnet.it/TFI/Allegati.aspx?file=2012-01-007453-Diaglimet.pdf''monografia''] | ||
+ | *'''[[Glibomet]]''' 40CPR RIV 2,5+400MG, 60CPR RIV 5+400MG [http://www.dottnet.it/TFI/Allegati.aspx?file=2012-07-003735-Glibomet.pdf''monografia''] | ||
+ | *'''[[Gliconorm]]''' 36CPR RIV 5MG+500MG [http://www.dottnet.it/TFI/Allegati.aspx?file=2013-02-003787-Gliconorm.pdf''monografia''] | ||
+ | *'''[[Glicorest]]''' 36CPR RIV 5MG+500MG [http://www.dottnet.it/TFI/Allegati.aspx?file=2013-01-003758-Glicorest.pdf''monografia''] | ||
+ | *'''[[Suguan M]]''' 40CPR RIV 2,5MG+400MG [http://www.dottnet.it/TFI/Allegati.aspx?file=2007-09-005527-Suguan%20M.pdf''monografia''] | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | *'''[[Competact]]''' 56cpr 15MG/850MG [http://www.ema.europa.eu/docs/it_IT/document_library/EPAR_-_Summary_for_the_public/human/000655/WC500032621.pdf | + | '''PIOGLITAZONE/METFORMINA:''' |
− | *'''[[Glubrava]]''' 56 cpr 15MG/850MG [http://www.ema.europa.eu/docs/it_IT/document_library/EPAR_-_Summary_for_the_public/human/000893/WC500022882.pdf | + | *'''[[Competact]]''' 56cpr 15MG/850MG [http://www.ema.europa.eu/docs/it_IT/document_library/EPAR_-_Summary_for_the_public/human/000655/WC500032621.pdf''Riassunto EMA''], [http://www.dottnet.it/TFI/Allegati.aspx?file=2010-06-005030-Competact.pdf''monografia''] |
+ | *'''[[Glubrava]]''' 56 cpr 15MG/850MG [http://www.ema.europa.eu/docs/it_IT/document_library/EPAR_-_Summary_for_the_public/human/000893/WC500022882.pdf''Riassunto EMA''], [http://www.dottnet.it/TFI/Allegati.aspx?file=2009-09-007901-Glubrava.pdf''monografia''] | ||
− | |||
− | *'''[[Jentadueto]]''' cpr 2,5mg+850mg, cpr 2,5mg+1000mg [http://www.ema.europa.eu/docs/it_IT/document_library/EPAR_-_Summary_for_the_public/human/002279/WC500130971.pdf | + | '''[[Linagliptin|LINAGLIPTIN]]/METFORMINA:''' |
+ | *'''[[Jentadueto]]''' cpr 2,5mg+850mg, cpr 2,5mg+1000mg [http://www.ema.europa.eu/docs/it_IT/document_library/EPAR_-_Summary_for_the_public/human/002279/WC500130971.pdf''Riassunto EMA''] | ||
− | |||
+ | '''SITAGLIPTIN / [[Metformina|METFORMINA]]:''' | ||
*'''[[Efficib]]''' [http://www.dottnet.it/TFI/Allegati.aspx?file=2013-11-007257-Efficib+50mg-850mg.pdf cpr 50mg+850mg], [http://www.dottnet.it/TFI/Allegati.aspx?file=2013-11-007255-Efficib+50mg-1000mg.pdf cpr 50mg+1000mg] [http://www.ema.europa.eu/docs/it_IT/document_library/EPAR_-_Summary_for_the_public/human/000896/WC500021375.pdf <i>Riassunto EMA</i>] | *'''[[Efficib]]''' [http://www.dottnet.it/TFI/Allegati.aspx?file=2013-11-007257-Efficib+50mg-850mg.pdf cpr 50mg+850mg], [http://www.dottnet.it/TFI/Allegati.aspx?file=2013-11-007255-Efficib+50mg-1000mg.pdf cpr 50mg+1000mg] [http://www.ema.europa.eu/docs/it_IT/document_library/EPAR_-_Summary_for_the_public/human/000896/WC500021375.pdf <i>Riassunto EMA</i>] | ||
*'''[[Janumet]]''' [http://www.dottnet.it/TFI/Allegati.aspx?file=2011-02-007233-Janumet+50mg-850mg.pdf cpr 50mg+850mg], [http://www.dottnet.it/TFI/Allegati.aspx?file=2011-02-007234-Janumet+50mg-1000mg.pdf cpr 50mg+1000mg] [http://www.ema.europa.eu/docs/it_IT/document_library/EPAR_-_Summary_for_the_public/human/000861/WC500038807.pdf <i>Riassunto EMA</i>] | *'''[[Janumet]]''' [http://www.dottnet.it/TFI/Allegati.aspx?file=2011-02-007233-Janumet+50mg-850mg.pdf cpr 50mg+850mg], [http://www.dottnet.it/TFI/Allegati.aspx?file=2011-02-007234-Janumet+50mg-1000mg.pdf cpr 50mg+1000mg] [http://www.ema.europa.eu/docs/it_IT/document_library/EPAR_-_Summary_for_the_public/human/000861/WC500038807.pdf <i>Riassunto EMA</i>] | ||
*'''[[Velmetia]]''' [http://www.dottnet.it/TFI/Allegati.aspx?file=2013-06-007237-Velmetia+50mg-850mg+cpr.pdf cpr 50mg+850mg], [http://www.dottnet.it/TFI/Allegati.aspx?file=2013-06-007239-Velmetia+50mg-1000mg+cpr.pdf cpr 50mg+1000mg] [http://www.ema.europa.eu/docs/it_IT/document_library/EPAR_-_Summary_for_the_public/human/000862/WC500048251.pdf <i>Riassunto EMA</i>] | *'''[[Velmetia]]''' [http://www.dottnet.it/TFI/Allegati.aspx?file=2013-06-007237-Velmetia+50mg-850mg+cpr.pdf cpr 50mg+850mg], [http://www.dottnet.it/TFI/Allegati.aspx?file=2013-06-007239-Velmetia+50mg-1000mg+cpr.pdf cpr 50mg+1000mg] [http://www.ema.europa.eu/docs/it_IT/document_library/EPAR_-_Summary_for_the_public/human/000862/WC500048251.pdf <i>Riassunto EMA</i>] | ||
− | |||
− | *'''[[Eucreas]]''' [http://www.ema.europa.eu/docs/it_IT/document_library/EPAR_-_Summary_for_the_public/human/000807/WC500030595.pdf | + | '''VILDAGLIPTIN / [[Metformina|METFORMINA]]''' |
− | **cpr 50mg+850mg [http://www.dottnet.it/TFI/Allegati.aspx?file=2013-11-007123-Eucreas+50mg%2b850mg.pdf | + | *'''[[Eucreas]]''' [http://www.ema.europa.eu/docs/it_IT/document_library/EPAR_-_Summary_for_the_public/human/000807/WC500030595.pdf''riassunto EMA''] |
− | **cpr 50mg+1000mg [http://www.dottnet.it/TFI/Allegati.aspx?file=2013-11-007122-Eucreas+50mg%2b1000mg.pdf | + | **cpr 50mg+850mg [http://www.dottnet.it/TFI/Allegati.aspx?file=2013-11-007123-Eucreas+50mg%2b850mg.pdf''monografia''] |
+ | **cpr 50mg+1000mg [http://www.dottnet.it/TFI/Allegati.aspx?file=2013-11-007122-Eucreas+50mg%2b1000mg.pdf''monografia''] | ||
== STRUTTURA == | == STRUTTURA == | ||
Riga 99: | Riga 96: | ||
[[Categoria:Ipoglicemizzanti]] | [[Categoria:Ipoglicemizzanti]] | ||
[[Categoria:Biguanidi]] | [[Categoria:Biguanidi]] | ||
− | {{Diabete}} | + | |
+ | |||
+ | {{#seo: | ||
+ | |title=Metformina (Glucophage, Metbay, Metfonorm, Metforal, Zuglimet) | ||
+ | |titlemode=append | ||
+ | |keywords=Glucophage,Metbay,Metfonorm,Metforal,Zuglimet,Diabete,biguanidi,metformina,glicemia. | ||
+ | |description=La Metformina agisce diminuendo la gluconeogenesi a livello epatico , riducendo in questo modo la produzione di glucosio. | ||
+ | }} |